Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

Trump to unveil TrumpRx discounted drugs website
5 Feb 2026

Trump to unveil TrumpRx discounted drugs website

WASHINGTON, Feb 5 (Reuters) - U.S. ‍President Donald Trump plans to unveil TrumpRx.gov on Thursday, a website meant to offer consumers access to disco...

Syngenta plans Hong Kong listing worth up to $10 billion, sources say
5 Feb 2026

Syngenta plans Hong Kong listing worth up to $10 billion, sources say

ZURICH/HONG KONG, Feb 5 (Reuters) - Syngenta Group is targeting a Hong Kong listing that could raise as much as $10 billion, two sources with knowledg...

FTSE 100 retreats from record high as tech selloff offsets gains in miners
3 Feb 2026

FTSE 100 retreats from record high as tech selloff offsets gains in miners

Feb 3 (Reuters) - London's ‍FTSE 100 pulled back from a record high on Tuesday as losses in AI-exposed stocks outweighed gains ⁠in miners, with invest...

LONDON MARKET MIDDAY: FTSE 100 down as rally falters, gold rebounds
3 Feb 2026

LONDON MARKET MIDDAY: FTSE 100 down as rally falters, gold rebounds

(Alliance News) - Stock prices in London were lower at midday on Tuesday, as an earlier rally in the FTSE 100, which sent it to a new intraday record,...

AstraZeneca says FDA backs Datroway, seeks more assurance on Saphnelo
3 Feb 2026

AstraZeneca says FDA backs Datroway, seeks more assurance on Saphnelo

(Alliance News) - AstraZeneca PLC on Tuesday reported mixed news with progress for its cancer treatment Datroway, while US regulatory authorities requ...

US FDA rejects AstraZeneca's easier-to-use version of lupus therapy
3 Feb 2026

US FDA rejects AstraZeneca's easier-to-use version of lupus therapy

Feb 3 (Reuters) - ‍AstraZeneca said on Tuesday that the U.S. health regulator had rejected its application for an easier-to-use ‍version of lupus ther...

LONDON BRIEFING: AG Barr adds drink brands; Filtronic profit falls
3 Feb 2026

LONDON BRIEFING: AG Barr adds drink brands; Filtronic profit falls

(Alliance News) - AG Barr reports revenue growth and buys soft drink brands Fentimans and Frobishers, while Filtronic expects to meet market expectati...